Show simple item record

dc.contributor.authorTree, AC
dc.contributor.authorDearnaley, DP
dc.date.accessioned2020-01-24T11:02:30Z
dc.date.issued2020-03-01
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2020, 32 (3), pp. 175 - 180
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3495
dc.identifier.eissn1433-2981
dc.identifier.doi10.1016/j.clon.2019.10.006
dc.description.abstractEvidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for prostate cancer radiotherapy, until the results of further phase III studies are known.
dc.formatPrint-Electronic
dc.format.extent175 - 180
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER SCIENCE LONDON
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectMale
dc.subjectStandard of Care
dc.subjectRadiation Dose Hypofractionation
dc.titleSeven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer.
dc.typeJournal Article
dcterms.dateAccepted2019-09-20
rioxxterms.versionofrecord10.1016/j.clon.2019.10.006
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2020-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue3
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley)
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley)
pubs.publication-statusPublished
pubs.volume32
pubs.embargo.termsNot known
icr.researchteamClinical Academic Radiotherapy (Dearnaley)
dc.contributor.icrauthorDearnaley, David


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record